This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Taro-Docusate Capsules USP 100 mg (2014-04-25)
- Starting date:
- April 25, 2014
- Posting date:
- May 2, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-39287
Recalled products
Taro-Docusate Capsules USP 100 mg
Reason
Foreign matter identified as inert nitrile rubber was found in a capsule.
Depth of distribution
Retailers in all provinces and territories except Yukon, Northwest Territories, Nunavut, and Prince Edward Island.
Affected products
Taro-Docusate Capsules USP 100 mg
DIN, NPN, DIN-HIM
DIN 00716731
Dosage form
Capsule
Strength
100 mg
Lot or serial number
- 230000505
- 230000506
- 230000507
- 230000508
- 230000509
- 230000510
- 230000491
- 230000428
- 230000516
Companies
- Recalling Firm
-
Taro Pharmaceuticals Inc.
130 East Drive
Brampton
L6T 1C1
Ontario
CANADA
- Marketing Authorization Holder
-
Taro Pharmaceuticals Inc.
130 East Drive
Brampton
L6T 1C1
Ontario
CANADA